Afederal appeals court preserved access to the abortion drug mifepristone but tightened rules to not allow the drug to be dispensed by mail and only allow it to be given to women up to seven weeks of gestation, not 10.
The New Orleans-based 5th U.S. Circuit Court of Appeals issued the ruling late Wednesday evening after the Biden administration appealed a decision from Texas U.S. District Judge Matthew Kacsmaryk, a Trump appointee who ruled that the Food and Drug Administration violated federal standards by rushing the pill’s approval process.